GGrantIndex
Sort

261,768 grants matching gene therapy

A Blueprint for Oncogenic Epigenetic Reprogramming

$2,310,000
Siavash Kurdistani · University Of California Los Angeles · DP2 · FY2009 · OD

Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML

$2,309,994
Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2017 · CA

Ebola Vaccine Development

$2,309,604
Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Hair Cell Development in the Mammalian Cochlea

$2,309,596
Matthew Kelley · National Institute On Deafness And Other Communication Disorders · ZIA · FY2015 · DC

Translational Immunopsychiatry Unit

$2,309,309
Christopher Bartley · National Institute Of Mental Health · ZIA · FY2023 · MH

Defining regulators of immunity to acute infection using CRISPR screens

$2,309,197
Arlene H Sharpe · Harvard Medical School · U19 · FY2019 · AI

MD Anderson Cancer Center SPORE in Gastrointestinal Cancer

$2,309,154
Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA

PPG - Gene Therapy for Cystic Fibrosis Lung Disease

$2,308,898
Paul B McCray · University Of Iowa · P01 · FY2009 · HL

Gene-Environment Interactions at the Skin Surface

$2,308,668
Julie Segre · National Human Genome Research Institute · ZIA · FY2012 · HG

CANCER CENTER SUPPORT GRANT

$2,308,192
City Of Hope/Beckman Research Institute · P30 · FY2004 · CA

Translational development of new agents alone and in combination to combat Gram-negative pathogens important in Ventilator- Associated Bacterial Pneumonia: Leveraging the Gram-negative toolbox that is

$2,308,174
George Louis Drusano · University Of Florida · P01 · FY2024 · AI

Development of Novel Therapeutic Strategies in Human Leukemias

$2,307,647
Benjamin Levine Ebert · Brigham And Women'S Hospital · P01 · FY2014 · CA

City of Hope Lymphoma SPORE

$2,307,384
Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2022 · CA

Growth Factor Imaging and Photoimmunotherapy

$2,307,149
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Metal-Catalyzed Oxidation Of Proteins

$2,306,861
Rodney L. Levine · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL

Architecture and control of exocytosis and endocytosis in excitable cells

$2,306,822
Justin Taraska · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

GENERAL CLINICAL RESEARCH CENTER

$2,306,787
University Of Texas Sw Med Ctr/Dallas · M01 · FY2001 · RR

Development of Novel Therapeutic Strategies in Human Leukemias

$2,306,268
James D Griffin · Dana-Farber Cancer Inst · P01 · FY2011 · CA

Brain Tumor SPORE Grant

$2,305,947
Mitchel S. Berger · University Of California, San Francisco · P50 · FY2022 · CA

Center for Cancer Immunology and Immunotherapy (CCII)

$2,305,905
Jun Yan · University Of Louisville · P20 · FY2023 · GM

Neutralizing Antibody & AAV FIX Gene Therapy

$2,305,824
Aravind Asokan · Univ Of North Carolina Chapel Hill · P01 · FY2016 · HL

?Resetting immune homeostasis: a non-invasive approach towards HIV eradication

$2,305,584
Rafick-Pierre Sekaly · Case Western Reserve University · U01 · FY2017 · AI

MGH/MIT MORRIS UDALL CENTER OF EXCELLENCE IN PD RESEARCH

$2,305,395
Anne B Young · Massachusetts General Hospital · P50 · FY2006 · NS

Improving Cardiac Function After Myocardial Infarction

$2,305,267
Steven R Houser · Temple Univ Of The Commonwealth · P01 · FY2012 · HL

Epidemiology of Ovarian Cancer in African-American Women

$2,304,983
Joellen M. Schildkraut · Duke University · R01 · FY2014 · CA